MAJESTY: A Phase 3, Randomized, Open-Label, Active Comparator-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy

Details

Language :

English

ISSN :

10466673 and 15333450

Volume :

35

Issue :

10, Number 10 Supplement 10

Database :

Supplemental Index

Journal :

Journal of the American Society of Nephrology

Publication Type :

Periodical

Accession number :

ejs68471596

Full Text :

https://doi.org/10.1681/ASN.2024bg7j9nj3